According to a study published in Psycho‐Oncology, patients with newly diagnosed malignant lymphoma or multiple myeloma who reported depressive symptoms prior to the start of chemotherapy had poorer survival compared with patients who were not initially depressed. The prospective analysis was conducted at the Nagoya City University Hospital in Japan. Researchers sought to investigate the…
A study affirmed the benefits of a multimodal approach in the assessment of minimal residual disease in multiple myeloma.
Choosing the best bridging therapy for a patient, prior to administration of CAR-T, is dependent on the patient’s disease characteristics.
Mutated ATM and unmutated IGHV were identified as potential early drivers of disease in treatment-naive patients with chronic lymphocytic leukemia.
Another study showed that surveillance imaging for patients with follicular lymphoma did not improve survival outcomes after first relapse.
Risk for death higher even with depression remission versus never experiencing depression.
Bispecific CAR-T cells were engineered to target both tumor antigen and vaccine-specific antigens to boost CAR-T function through an amphiphilic vaccine.
A case report suggests that endoscopic techniques may have utility in the diagnosis of the gastric involvement that can occur in follicular lymphoma.
In this retrospective study, researchers investigated whether assessing left ventricular diastolic function in patients receiving carfilzomib for relapsed or refractory multiple myeloma improved risk of cardiovascular adverse events.
Inferior survival for patients with chronic lymphocytic leukemia who progress with lymphadenopathy.
